Cardiac effects of stroke

Current Treatment Options in Cardiovascular Medicine

Volumn 6, Issue 3, 2004, Pages 199-207

  Cheung, Raymond T F ^a   Hachinski, Vladimir ^b  

^a QUEEN MARY HOSPITAL   (Hong Kong)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; DIGOXIN; DOPAMINE; ENALAPRIL; ESMOLOL; FLECAINIDE; HYDRALAZINE; LABETALOL; LIDOCAINE; MEXILETINE; NICARDIPINE; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; PROPAFENONE; QUINIDINE; SOTALOL; VERAPAMIL;

ADRENERGIC SYSTEM; AMYGDALOID NUCLEUS; ARTICLE; BRAIN HEMORRHAGE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; DISEASE ASSOCIATION; DISEASE SEVERITY; ECG ABNORMALITY; ELECTROCARDIOGRAPHY; HEART ARRHYTHMIA; HEART SUPRAVENTRICULAR ARRHYTHMIA; HUMAN; HYPERTENSION; HYPOTENSION; INSULA; PATIENT MONITORING; QT PROLONGATION; STROKE; SUBARACHNOID HEMORRHAGE;

EID: 5544263495     PISSN: 10928464     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11936-996-0014-x     Document Type: Article

References (22)

1. Cheung RTF: The utility of melatonin in reducing cerebral damage resulting from ischemia and reperfusion. J Pineal Res 2003, 34: 153-160.
2. Cheung RTF, Hachinski V: Cardiology. In Hospitalist Neurology (Blue Books of Practical Neurology, vol 19). Edited by Samuels MA. Boston: Butterworth-Heinemann Medical; 1999:305-330.
3. Cheung RTF, Hachinski V: Cardiac rhythm disorders and muscle changes with cerebral lesions. Adv Neurol 2003, 92: 213-220.
4. Cheung RTF, Hachinski V: The insula and cerebrogenic sudden death. Arch Neurol 2000, 57: 1685-1688.
5. Adams HP Jr, Adams RJ, Brott T, et al.: Guidelines for the early management of patients with ischemic stroke. A scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003, 34: 1056-1083.
6. Bertinchant JP, Robert E, Polge A, et al.: Comparison of the diagnostic value of cardiac troponin I and T determinations for detecting early myocardial damage and the relationship with histological findings after isoprenaline-induced cardiac injury in rats. Clin Chim Acta 2000, 298: 13-28.
7. James P, Ellis CJ, Whitlock RM, et al.: Relation between troponin T concentration and mortality in patients presenting with an acute stroke: observational study. BMJ 2000, 320: 1502-1504.
8. Ay H, Arsava EM, Saribas O: Creatine kinase-MB elevation after stroke is not cardiac in origin. Comparison with troponin T levels Stroke 2002, 33: 286-289.
9. Sander D, Klingelhöfer J: Changes of circadian blood pressure patterns after hemodynamic and thromboembolic brain infarction Stroke 1994, 25: 1730-1737.
10. Sander D, Klingelhöfer J: Stroke-associated pathological sympathetic activation related to size of infarction and extent of insular damage. Cerebrovasc Dis 1995, 5 : 381-385.
11. Klingelhöfer J, Sander D: Cardiovascular consequences of clinical stroke. Baillieres Clin Neurol 1997, 6: 309-335.
12. Sander D, Winbeck K, Klingelhöfer J, et al.: Prognostic relevance of pathological sympathetic activation after acute thromboembolic stroke. Neurology 2001, 57: 833-838.
13. Tokgözoglu SL, Batur MK, Topçuoglu MA, et al.: Effects of stroke localization on cardiac autonomic balance and sudden death. Stroke 1999, 30: 1307-1311.
14. Korpelainen JT, Sotaniemi KA, Mäkikallio A, et al.: Dynamic behavior of heart rate in ischemic stroke. Stroke 1999, 30: 1008-1013.
15. Megli B, Kobal J, Osredkar J, Pogak T: Autonomic nervous system function in patients with acute brainstem stroke. Cerebrovasc Dis 2001, 11: 2-8.
16. Oppenheimer SM: Management of cardiac/ECG complications of stroke. In Primer on Cerebrovascular Diseases. Edited by Welch K, et al. New York: Academic Press; 1997:692-696.
17. Erciyas AH, Topalkara K, Topaktas S, et al.: Suppression of cardiac parasympathetic functions in patients with right hemispheric stroke. Eur J Neurol 1999, 6: 685-690.
18. Blomström-Lundqvist, Scheinman MM, Aliot EM, et al.: ACC/AHA/ESC Guidelines for the management of patients with supraventricular arrhythmias - executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias). J Am Coll Cardiol 2003, 42: 1493-1531.
19. McNamara RL, Tamartz LJ, Segal JB, Bass EB: Management of atrial fibrillation: review of the evidence for the role of pharmacologic therapy, electrical cardioversion, and echocardiography. Ann Intern Med 2003, 139: 1018-1033.
20. Fischer A, Verma R, Comes JA, Mehta D: Ventricular arrhythmia: role of the implantable cardioverter defibrillator and radiofrequency ablation in addition to drugs. Mount Sinai J Med 2002, 69: 197-207.
21. Mayberg MR, Batjer HH, Dacey R, et al.: Guidelines for management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1994, 25: 2315-2328.
22. Broderick JP, Adams HP Jr, Barsan W, et al.: Guidelines for the management of spontaneous intracerebral hemorrhage. Stroke 1999, 30: 905-915.